BSE · ADLINE
ADLINE CHEM LAB LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,547
of 5,004 stocks
🏆 New peak
▲ 1031W
Peak #4,547 · 01 Oct 2026
A microcap name in Healthcare, ADLINE CHEM LAB LIMITED carries a steep earnings multiple that prices in strong future growth, has a widely-held ownership base, with promoters at just 26%, and posts a modest return on equity.
Market Cap
8.80 Cr
P/E Ratio
752.00
P/B Ratio
—
ROE
8.88%
ROCE
-124.17%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q3 2025-26 | Q1 2025-26 | Q4 2024-25 |
|---|---|---|---|---|
| Revenue | Rs 0 | Rs 0 | Rs 0 | Rs 0 |
| Net Profit | 4.01 L | -6.46 L | -5.13 L | 20.94 L |
| EPS | 0.07 | 0.01 | 0.01 | 0.04 |
| Operating Profit | 8.04 L | -3.00 L | -3.10 L | 19.11 L |
Shareholding pattern
Promoter
25.85%
Public
74.15%
PUBLIC BREAKDOWN
Individuals
73.55%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.